NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Rebel Medicine

Rebel Medicine

Private
Salt Lake City, UtahHealthcare & Life Scienceshttps://www.rebelmedicine.com/

Last Round

Series A

Jun 4, 2026

Total Funding Raised

$11.16M

Momentum

Top 10%

of companies Caplight tracks

Company Overview

Rebel Medicine is a biotechnology company that develops non-opioid pharmaceutical products for acute and post-operative pain management.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials, Medical Devices

Business Model

B2B

Customer Profile

Services & Consulting, Government Contracts

AI Layer

Non-AI

Keywords

non-opioid pain managementextended-release anestheticspostoperative analgesiadrug delivery technologypain managementopioid-sparingbiotechnologylocal anestheticdrug-releasing dressingclinical-stage biotechinvestigational new drugINDnew drug applicationNDAnon-dilutive funding

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Rebel Medicine Comps

Public and private peers based on sector, stage, and business model.

Rebel Medicine comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Rebel Medicine Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series AJun 4, 2026
Series AJun 12, 2025
SeedFeb 6, 2025
GrantSep 1, 2020

Key People

Founding team and executive leadership

Caleb Lade

Co-Founder, COO

Founding Team

Brett Davis

Co-Founder CEO

Founding Team

Rebel Medicine Investors

Notable investors and investment history

Rebel Medicine investors
InvestorRounds
U.S. Department of Health and Human ServicesGrant
Utah Innovation FundSeries A
Central Texas Angel NetworkSeries A, Seed
S.K. Hart ManagementSeries A
Crocker VenturesSeed, Series A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 4, 2026

    $9M raised in Seed Round.

  • Apr 15, 2026

    Monthly visitors increased 170% MoM.

Rebel Medicine Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Rebel Medicine Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Rebel Medicine's valuation, stock price, and market status.

Firmographic Details

HeadquartersSalt Lake City, Utah
Employee Range13
Year Founded2020
Last FundingJun 4, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.